FDA Okays New Drug for Resistant Hypertension FDA Okays New Drug for Resistant Hypertension
Aprocitentan is the first endothelin receptor antagonist approved to lower blood pressure, in combination with other antihypertensives, in treatment-resistant hypertension.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news